Last reviewed · How we verify
Multiple administration Amg dose group
At a glance
| Generic name | Multiple administration Amg dose group |
|---|---|
| Sponsor | J2H Biotech |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males (PHASE1)
- Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers (PHASE1)
- Phase 2 AMG 714 in Rheumatoid Arthritis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Multiple administration Amg dose group CI brief — competitive landscape report
- Multiple administration Amg dose group updates RSS · CI watch RSS
- J2H Biotech portfolio CI